(2024)
Omicron BA.2 breakthrough infection elicits CD8+ T cell responses recognizing the spike of later Omicron subvariants.
SCIENCE IMMUNOLOGY.
9,
91
(2023)
Clinical utility of quantitative immunoassays and surrogate virus neutralization tests for predicting neutralizing activity against the SARS-CoV-2 Omicron BA.1 and BA.5 variants..
JOURNAL OF MEDICAL VIROLOGY.
95,
12
(2023)
False-positive Aspergillus galactomannan immunoassay in the glucose component of total parenteral nutrition products.
MICROBIOLOGY SPECTRUM.
11,
6
(2023)
Evolution of neutralizing antibodies through vaccination and breakthrough infections in the era of COVID-19 endemicity..
JOURNAL OF MEDICAL VIROLOGY.
95,
12
(2023)
Longitudinal kinetics of neutralizing antibodies against circulating SARS-CoV-2 variants and estimated level of group immunity of booster-vaccinated individuals during omicron-dominated COVID-19 outbreaks in the Republic of Korea, 2022.
MICROBIOLOGY SPECTRUM.
11,
5
(2023)
Immune Response Kinetics Following a Third Heterologous BNT162b2 Booster Dose After Primary 2-Dose ChAdOx1 Vaccination in Relation to Omicron Breakthrough Infection: A Prospective Nationwide Cohort Study in South Korea.
OPEN FORUM INFECTIOUS DISEASES.
10,
7
(2023)
Loss of Neutralizing Activity of Tixagevimab/Cilgavimab (Evusheld™) Against Omicron BN.1, a Dominant Circulating Strain Following BA.5 During the Seventh Domestic Outbreak in Korea in Early 2023.
JOURNAL OF KOREAN MEDICAL SCIENCE.
38,
27
(2023)
Triple immune modulator therapy for aberrant hyperinflammatory responses in severe COVID-19.
CLINICAL IMMUNOLOGY.
251,
na
(2023)
Effectiveness of regdanvimab treatment for SARS-CoV-2 delta variant, which exhibited decreased in vitro activity: a nationwide real-world multicenter cohort study.
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY.
13,
na
(2023)
Augmented humoral and cellular immunity against severe acute respiratory syndrome coronavirus 2 after breakthrough infection in kidney transplant recipients who received 3 doses of coronavirus disease 2019 vaccine.
AMERICAN JOURNAL OF TRANSPLANTATION.
23,
4
(2023)
Corticosteroids reduce pathologic interferon responses by downregulating STAT1 in patients with high-risk COVID-19.
EXPERIMENTAL AND MOLECULAR MEDICINE.
55,
3
(2023)
A heterologous AZD1222 priming and BNT162b2 boosting regimen more efficiently elicits neutralizing antibodies, but not memory T cells, than the homologous BNT162b2 regimen.
VACCINE.
41,
10
(2023)
Neutralizing activity against Omicron BA.5 after tixagevimab/cilgavimab administration comparable to those after Omicron BA.1/BA.2 breakthrough infections..
FRONTIERS IN IMMUNOLOGY.
14,
na
